Showing results (101-110 of 178) with videos related to
Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynxCaroline Hoffmann, Valentin Calugaru, Edith Borcoman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumorsJonathan Goldman, S Gail Eckhardt, Mitesh J Borad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid TumorsRastislav Bahleda, Antoine Italiano, Cinta Hierro, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancerThomas Wehler, Michael Thomas, Christian Schumann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric CancerYelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.Investigational New Drugs|November 28, 2017
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trialEmiliano Calvo, Analia Azaro, Jordi Rodon, et al.Journal of Clinical Medicine|February 5, 2021
Trends and Clinical Impact of Gastrointestinal Endoscopic Procedures on Acute Heart Failure in Spain (2002-2017)Manuel Méndez-Bailón, Rodrigo Jiménez-García, Nuria Muñoz-Rivas, et al.BMC Cancer|February 17, 2017
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patientsBerta Laquente, Jose Lopez-Martin, Donald Richards, et al.Investigational New Drugs|June 20, 2014
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancerEmiliano Calvo, Victor J Chen, Mark Marshall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell ResponsesAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.Pageof 18